Story
Bone research in thalassaemia is crucial for understanding the impact of the disease on bone health, identifying optimal therapeutic measures, and improving the care and management of individuals with thalassaemia.
For the past 46 years we have concentrated in improving patient care. We raised over 4 million pounds in total used to develop new therapies and treatment which included the iron chelation medication which reduced patient deaths, medical equipment and software and educational literature which is now used internationally.
While this has improved life significantly we are aware that we needed to focus on issues now being faced by patients as young as 2 years old. Bone pain has now been cited as one of the biggest issues being faced and we are extremely fortunate to have one of the leading experts in the UK ready to lead research.
Funding is an issue as although this is urgently needed, thalassaemia is not one of the designer conditions and there is little or no support from most of the decision makers.
This is why we need YOUR support. Help us to support this necessary research.
Campaign by 